down arrow

Krebs Biochem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
73.81
2.81 (3.96%)
BSENSE

Apr 11, 12:16 PM

BSE+NSE Vol: 2.64 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

73.0075.40

52 Week

60.30129.00
Valuation
Technical
Day's Volume

CASH

2.64 k (-46.43%) Volume

Shareholding (Mar 2025)

FII

0.50%

Held by 5 FIIs

DII

-0.00%

Held by 0 DIIs

Promoter

72.74%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 10.12% and Operating profit at 0% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 159 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

27

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.57

stock-summary
Return on Equity

18.84%

stock-summary
Price to Book

-1.18

Revenue and Profits (1 Year):
Net Sales:
11 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-8 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-8.8%
0%
-8.8%
1 Year
4.65%
0%
4.65%
2 Years
-10.44%
0%
-10.44%
3 Years
-58.19%
0%
-58.19%
4 Years
-35.34%
0%
-35.34%
5 Years
-0.19%
0%
-0.19%

Krebs Biochem for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.12%
EBIT Growth (5y)
1.86%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.50%
ROCE (avg)
-40.00%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
27
Price to Book Value
-1.18
EV to EBIT
-18.31
EV to EBITDA
-28.06
EV to Capital Employed
4.81
EV to Sales
7.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-22.78%
ROE (Latest)
Negative BV
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 5 FIIs (0.5%)

Promoter with highest holding

Ipca Laboratories Limited (49.65%)

Highest Public shareholder

Sun Pharmaceutical Industries Ltd (4.81%)

Individual Investors Holdings

20.42%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -11.63% vs 42.79% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -55.42% vs 10.27% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.47",
          "val2": "12.98",
          "chgp": "-11.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.71",
          "val2": "-2.09",
          "chgp": "-125.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.56",
          "val2": "1.19",
          "chgp": "31.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-7.74",
          "val2": "-4.98",
          "chgp": "-55.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-41.06%",
          "val2": "-16.10%",
          "chgp": "-24.96%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 1.06% vs -19.35% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -22.81% vs 27.05% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.74",
          "val2": "25.47",
          "chgp": "1.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.91",
          "val2": "-3.53",
          "chgp": "-39.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.74",
          "val2": "2.23",
          "chgp": "22.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-10.93",
          "val2": "-8.90",
          "chgp": "-22.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-19.08%",
          "val2": "-13.86%",
          "chgp": "-5.22%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -3.22% vs -5.46% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -34.51% vs 21.80% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.21",
          "val2": "38.45",
          "chgp": "-3.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.62",
          "val2": "-5.62",
          "chgp": "-71.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.30",
          "val2": "3.42",
          "chgp": "25.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-18.67",
          "val2": "-13.88",
          "chgp": "-34.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-25.85%",
          "val2": "-14.62%",
          "chgp": "-11.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -3.28% vs -1.53% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 20.09% vs 44.55% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.42",
          "val2": "52.13",
          "chgp": "-3.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.72",
          "val2": "-15.78",
          "chgp": "44.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.69",
          "val2": "2.97",
          "chgp": "57.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-19.73",
          "val2": "-24.69",
          "chgp": "20.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-17.29%",
          "val2": "-30.27%",
          "chgp": "12.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
11.47
12.98
-11.63%
Operating Profit (PBDIT) excl Other Income
-4.71
-2.09
-125.36%
Interest
1.56
1.19
31.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
-7.74
-4.98
-55.42%
Operating Profit Margin (Excl OI)
-41.06%
-16.10%
-24.96%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is -11.63% vs 42.79% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -55.42% vs 10.27% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
25.74
25.47
1.06%
Operating Profit (PBDIT) excl Other Income
-4.91
-3.53
-39.09%
Interest
2.74
2.23
22.87%
Exceptional Items
0.00
0.00
Standalone Net Profit
-10.93
-8.90
-22.81%
Operating Profit Margin (Excl OI)
-19.08%
-13.86%
-5.22%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 1.06% vs -19.35% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -22.81% vs 27.05% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
37.21
38.45
-3.22%
Operating Profit (PBDIT) excl Other Income
-9.62
-5.62
-71.17%
Interest
4.30
3.42
25.73%
Exceptional Items
0.00
0.00
Standalone Net Profit
-18.67
-13.88
-34.51%
Operating Profit Margin (Excl OI)
-25.85%
-14.62%
-11.23%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -3.22% vs -5.46% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -34.51% vs 21.80% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
50.42
52.13
-3.28%
Operating Profit (PBDIT) excl Other Income
-8.72
-15.78
44.74%
Interest
4.69
2.97
57.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
-19.73
-24.69
20.09%
Operating Profit Margin (Excl OI)
-17.29%
-30.27%
12.98%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -3.28% vs -1.53% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 20.09% vs 44.55% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Krebs Biochemicals & Industries Ltd stock-summary
stock-summary
Krebs Biochemicals & Industries Ltd
Micro Cap
Pharmaceuticals & Drugs
Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
Company Coordinates stock-summary
Company Details
Kothapalli(V) Kasimkota(M), Anakapalli Vishakapatnam Andhra Pradesh : 531031
stock-summary
Tel: 91-040-6680 8040
stock-summary
http://www.krebsbiochem.com
stock-summary
investors@kerbsbiochem.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."